prostate cancer

Model predicts long term mortality risk from prostate cancer - EurekAlert!

UH Seidman Cancer Researchers: What is the ideal duration of hormone therapy for the treatment of prostate cancer? - EurekAlert!

Longitudinal analysis of 80,000 adults finds vegan diets reduce overall cancer risk by 24%, with a 43% reduction in prostate cancer in younger men. The study confirms vegans have the lowest cancer rates of all groups, offering protection superior to standard vegetarian diets.

LSU LCMC Health Cancer Center researcher led major study identifies proteins linked to prostate cancer - EurekAlert!

Study suggests many men may not need long-term hormone therapy for prostate cancer - EurekAlert!

New therapeutic strategies show promise against a hard-to-treat prostate cancer - EurekAlert!

New imaging probe helps track, possibly treat, prostate cancer before resistance to treatment develops - EurekAlert!

CRISPR screen identifies new regulator of androgen receptor in prostate cancer - EurekAlert!

New Drug Combination Found to Slow One of the Deadliest Forms of Prostate Cancer

New tracer could enable surgeons to see and hear prostate cancer - EurekAlert!

Prostate cancer explained: From antigen tests to treatment options - EurekAlert!

Scientists uncover immune cells that help prostate cancer resist treatment — and reveal a way to stop them - EurekAlert!

Study reveals mechanisms behind common mutation and prostate cancer - EurekAlert!

The glucocorticoid receptor is a double-edged sword in prostate cancer - EurekAlert!

A study led by CIC bioGUNE delves into the complexity of the most aggressive form of prostate cancer - EurekAlert!

Biden’s prostate cancer is incurable, but it is treatable

Diabetes drug gives hope for new treatment for prostate cancer - e3.eurekalert.org

How Do Doctors Treat ‘Aggressive’ Prostate Cancer like Joe Biden’s?

Advanced imaging and targeted therapy help men with prostate cancer safely defer surgery and radiation therapy - EurekAlert!

Two-week radiotherapy proven as safe and effective as eight-week course for prostate cancer, after 10-year follow-up in phase III trial - EurekAlert!